search
Back to results

Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy

Primary Purpose

Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Blood Flow Restriction Cuff
Sham and standard of Care Therapy
Sponsored by
Gaylord Hospital, Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Patellofemoral Pain Syndrome focused on measuring Blood Flow Restriction, Patellofemoral Pain Syndrome, Physical Therapy, Non-Specific Anterior Knee Pain

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of patellofemoral pain syndrome (PFPS) or non-specific anterior knee pain (NSAKP) and plan to attend Gaylord Specialty Healthcare Physical Therapy Exclusion Criteria: Member of a defined vulnerable population, women who are or suspected to be pregnant, prisoners, children under 15, or other protected populations Body mass of the leg preventing the cuff from fitting properly Radiographic evidence of osteoarthritis (β‰₯ Kellgren-Lawrence Grade 2) History of intra-articular injection into either knee within 3 -months Uncontrolled or untreated inflammatory disorder Acute inflammatory disorder Uncontrolled Diabetes and/or peripheral neuropathy, impaired circulation Uncontrolled cardiac conditions including uncontrolled hypertension Areas of thrombophlebitis, thrombosis Distal wounds or pain below the knee >4/10 History of or current rhabdomyolysis Prolonged immobilization (>3 months) Sickle cell anemia Lymphadenectomy Varicose veins, or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis Current infection at or below the level of cuff placement Malignancies in or below the area to be treated Other conditions/medications that would interfere with subject safety or data collection in the opinion of the PI Subjects with an increased risk of non-response as determined by the therapist Once entered in the study, a diagnosis change that affects participation

Sites / Locations

  • Gaylord Specialty Healthcare Outpatient Physical Therapy; Cheshire
  • Gaylord Specialty Healthcare Outpatient Physical Therapy; Cromwell
  • University of Connecticut Health Center
  • Gaylord Specialty Healthcare Outpatient Physical Therapy; Madison
  • Gaylord Hospital
  • Gaylord Specialty Healthcare Outpatient Physical Therapy; Wallingford

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Blood flow restriction and standard of care therapy

Sham and standard of care therapy

Arm Description

The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.

The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.

Outcomes

Primary Outcome Measures

Numeric Pain Rating Scale: Enrollment
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Numeric Pain Rating Scale: 1 Week
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Numeric Pain Rating Scale: 4 Weeks
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Numeric Pain Rating Scale: 9 Weeks/Discharge
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Numeric Pain Rating Scale: 6 Months
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Numeric Pain Rating Scale: 12 Months
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Lower Extremity Functional Scale: Enrollment
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Lower Extremity Functional Scale: 1 Week
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Lower Extremity Functional Scale: 4 Weeks
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Lower Extremity Functional Scale: 9 Weeks/Discharge
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Lower Extremity Functional Scale: 6 Months
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Lower Extremity Functional Scale: 12 Months
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: Enrollment
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 1 Week
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 4 Weeks
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 9 Weeks/Discharge
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 6 Months
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 12 Months
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Single Assessment Numerical Evaluation: Enrollment
The SANE is a two item questionnaire used globally to assess function
Single Assessment Numerical Evaluation: 1 Week
The SANE is a two item questionnaire used globally to assess function
Single Assessment Numerical Evaluation: 4 Weeks
The SANE is a two item questionnaire used globally to assess function
Single Assessment Numerical Evaluation: 9 Weeks/Discharge
The SANE is a two item questionnaire used globally to assess function
Single Assessment Numerical Evaluation: 6 Months
The SANE is a two item questionnaire used globally to assess function
Single Assessment Numerical Evaluation: 12 Months
The SANE is a two item questionnaire used globally to assess function
Tenger Activity Scale: Enrollment
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Tenger Activity Scale: 6 Months
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Tenger Activity Scale: 12 Months
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Fear Avoidance Beliefs Questionnaire: Enrollment
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Fear Avoidance Beliefs Questionnaire: 1 Week
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Fear Avoidance Beliefs Questionnaire: 4 Weeks
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Fear Avoidance Beliefs Questionnaire: 9 Weeks/Discharge
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Fear Avoidance Beliefs Questionnaire: 6 Months
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Fear Avoidance Beliefs Questionnaire: 12 Months
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Secondary Outcome Measures

Quadricep Isometric Strength: Enrollment
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Quadricep Isometric Strength: 1 Week
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Quadricep Isometric Strength: 4 Weeks
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Quadricep Isometric Strength: 9 Weeks/Discharge
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry

Full Information

First Posted
November 1, 2022
Last Updated
October 10, 2023
Sponsor
Gaylord Hospital, Inc
Collaborators
UConn Health
search

1. Study Identification

Unique Protocol Identification Number
NCT05617911
Brief Title
Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy
Official Title
Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Terminated
Why Stopped
Study terminated due to lack of recruitment.
Study Start Date
November 15, 2022 (Actual)
Primary Completion Date
October 10, 2023 (Actual)
Study Completion Date
October 10, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Gaylord Hospital, Inc
Collaborators
UConn Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
Detailed Description
Patellofemoral Pain Syndrome (PFPS), also known as Non-Specific Anterior Knee Pain (AKP), is a non-specific musculoskeletal condition characterized by loss of function and pain localized to the patella. PFPS affects up to 22% of the general population yearly, with females affected more so than males. Adolescents (28%, mixed gender) and elite athletes (up to 35% in knee dominant sports such as cycling) are also commonly affected, making this a relatively widespread condition. Additionally, PFPS has a generally unfavorable prognosis, with up to 40% of individuals failing conservative treatment after 1 year, and 57% reporting continued symptoms for 5 to 8-years following. Higher levels of baseline disability and longer duration of symptoms lead to an even poorer prognosis, making early recognition and novel treatments key. To complicate things further, the presence of negative psychosocial factors is commonly found in this population and may be a greater predictor of outcomes than physical ones. Previously, biomechanical factors, such as maltracking of the patella and chondromalacia, have been called into question as potential causes of PFPS symptoms. However, both are now thought to be potential consequences of having PFPS. That being said, PFPS is generally accepted as a non-specific condition as there may be a number of different structures implicated as potential nociceptive drivers, and determining the exact tissue does not seem to be important to overall management strategies. This finding, in connection with the high prevalence of negative psychosocial factors, points less to a physiologically driven condition, and more towards a pain driven condition. While this theoretically makes diagnosing and treatment selection more ubiquitous, there does not seem to be a clear treatment strategy that works best for all patients. Despite a clear biomechanical cause, adjusting exercise selection or technique to include different loads and forces on the patella is still warranted based on patient presentation. For example, during open chain knee extension, the lowest loads are placed on the patella between 90- and 45-degree flexion, and open chain between 0 and 60 degrees. People with PFPS often benefit from adjusting the exercise selection, technique and load. Recent research compared multiple different exercise strategies (combined core and hip work, knee work only, and open vs closed-chain), without any one program showing significant advantage over the others. A combination of these approaches may be best. One theme within PFPS exercise research that appears consistent is the high level of sensitivity and poor response to treatment where higher levels of pain are present. This is in contrast to tendon related pain, such as patellar tendinopathy, where working into moderate levels of pain seems to be helpful for outcomes. The main mechanism driving improvements following exercise therapy for PFPS is not hypertrophy, but rather thought to be exercise induced hypoalgesia. This is a phenomenon where performing both acute bouts, as well as regular exercise (aerobic and resistance), reduces pain both in the short and long terms. Since exercise seems to reduce pain in both local and distant sites of the exercising area, it is thought to provide both local and systemic pain reducing effects. The magnitude and duration of the exercise seems to play an important role as well, with higher intensity and longer durations of exercising producing greater effects. Since patients with PFPS are unable to achieve these desired parameters, alternative strategies need to be investigated. Two options may be blood flow restriction (BFR) therapy and low load training to failure, both of which may capture some of the hypoalgesic effects while minimizing AKP. BFR involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area. Exercise intensities generally range from 20-30% of the patients' 1 repetition maximum (1RM) weight, with relatively high repetitions (sometimes to failure); this is opposed to traditional resistance training at 70%+ of 1RM. BFR training has been demonstrated to amplify the effects of exercise induced hypoalgesia (in addition to a host of other physiological benefits) through unconfirmed mechanisms. Leading theories suggest that the lack of available oxygen to the exercising area may lead to: the activation of the endogenous opioid and cannabinoid systems; systemic changes to the cardiovascular system; or increased number of metabolites such as hydrogen ions and lactic acid, which may also be contributing factors. Clinical research on the application of BFR in patients with PFPS has been both limited and mixed, with only two trials having been conducted in this area. One study from 2017 looked at high-load with BFR placebo, versus low-load BFR with leg press and knee extensions. Only the high-load group showed a modest medium-term effect on pain, lowering it for ~24 hours after BFR over the training period. The other paper from 2022 included both knee and hip strengthening exercises, comparing a low-load BFR group versus a high-load training group with no placebo; of note, the programs were not equated in terms of exercises completed. In this study, no significant difference was observed between groups. To date, there have been limited to no sham arms in studies where a BFR cuff was used. Given the potential for placebo effects, this was an important consideration in the design of the study. Given the heterogeneity of these two studies, and the paucity of research in this area, the aim of the current study is to compare a low load training to failure (with BFR placebo) to low load BFR training to failure on the effect of pain related outcomes, function, strength and other measures. We hypothesize that BFR training will improve objective and subjective outcomes in patients with patellofemoral pain syndrome (PFPS) more than standard therapy with a sham BFR cuff. Research aim 1: Determine whether the use of BFR improves patient-perceived function through a series of subjective patient-reported outcome measurements (PROs) throughout long-term recovery compared to patients in the sham control group. While we anticipate both groups may show improvement over time, we hypothesize that patients using BFR and the prescribed physical therapy protocol will demonstrate significantly improved PRO scores compared to the sham control group. These PROs include the Lower Extremity Functional Scale (LEFS), Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain (KOOS-PF), the Single Assessment Numerical Evaluation (SANE), the Fear Avoidance Beliefs Questionnaire (FABQ), and Numerical Rating Scale (NRS) Pain Scale 1-10. Participants will be asked to complete PRO at the start of physical therapy (i.e. baseline), 4-weeks, 9-weeks or patient discharge if it is before the scheduled 9-week assessment, 6-month, and 12-month timepoints. Research aim 2: Determine whether the use of BFR improves objective outcome measurements throughout prescribed physical therapy sessions compared to patients in the control group. While we anticipate both groups may show improvement over time, we hypothesize that patients using BFR and the prescribed physical therapy protocol will demonstrate significantly improved quadriceps isometric strength over the sham control group. Outcomes will be measured at the start of the physical therapy (i.e. baseline), 4-weeks, and 9-weeks or patient discharge if it is before the scheduled 9-week assessment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome
Keywords
Blood Flow Restriction, Patellofemoral Pain Syndrome, Physical Therapy, Non-Specific Anterior Knee Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Blood flow restriction and standard of care therapy
Arm Type
Experimental
Arm Description
The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.
Arm Title
Sham and standard of care therapy
Arm Type
Placebo Comparator
Arm Description
The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.
Intervention Type
Device
Intervention Name(s)
Blood Flow Restriction Cuff
Intervention Description
Blood Flow Restriction (BFR) involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area.
Intervention Type
Procedure
Intervention Name(s)
Sham and standard of Care Therapy
Intervention Description
SoC PT + non-inflated BFR cuff
Primary Outcome Measure Information:
Title
Numeric Pain Rating Scale: Enrollment
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Numeric Pain Rating Scale: 1 Week
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected 1-week into treatment
Title
Numeric Pain Rating Scale: 4 Weeks
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Numeric Pain Rating Scale: 9 Weeks/Discharge
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Title
Numeric Pain Rating Scale: 6 Months
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected 6 months post start date.
Title
Numeric Pain Rating Scale: 12 Months
Description
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time Frame
This assessment will be collected 12 months post start date.
Title
Lower Extremity Functional Scale: Enrollment
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Lower Extremity Functional Scale: 1 Week
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected 1-week into treatment.
Title
Lower Extremity Functional Scale: 4 Weeks
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Lower Extremity Functional Scale: 9 Weeks/Discharge
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Title
Lower Extremity Functional Scale: 6 Months
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected 6 months post start date.
Title
Lower Extremity Functional Scale: 12 Months
Description
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time Frame
This assessment will be collected 12 months post start date.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: Enrollment
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 1 Week
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected1-week into treatment.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 4 Weeks
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 9 Weeks/Discharge
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 6 Months
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected 6 months post start date.
Title
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 12 Months
Description
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time Frame
This assessment will be collected 12 months post start date.
Title
Single Assessment Numerical Evaluation: Enrollment
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Single Assessment Numerical Evaluation: 1 Week
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected 1-week into treatment.
Title
Single Assessment Numerical Evaluation: 4 Weeks
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Single Assessment Numerical Evaluation: 9 Weeks/Discharge
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Title
Single Assessment Numerical Evaluation: 6 Months
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected 6 months post start date.
Title
Single Assessment Numerical Evaluation: 12 Months
Description
The SANE is a two item questionnaire used globally to assess function
Time Frame
This assessment will be collected 12 months post start date.
Title
Tenger Activity Scale: Enrollment
Description
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time Frame
This assessment will be collected upon enrollment.
Title
Tenger Activity Scale: 6 Months
Description
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time Frame
This assessment will be collected 6 months post start date.
Title
Tenger Activity Scale: 12 Months
Description
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time Frame
This assessment will be collected 12 months post start date.
Title
Fear Avoidance Beliefs Questionnaire: Enrollment
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Fear Avoidance Beliefs Questionnaire: 1 Week
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected 1-week into treatment.
Title
Fear Avoidance Beliefs Questionnaire: 4 Weeks
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Fear Avoidance Beliefs Questionnaire: 9 Weeks/Discharge
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Title
Fear Avoidance Beliefs Questionnaire: 6 Months
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected 6 months post start date.
Title
Fear Avoidance Beliefs Questionnaire: 12 Months
Description
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time Frame
This assessment will be collected 12 months post start date.
Secondary Outcome Measure Information:
Title
Quadricep Isometric Strength: Enrollment
Description
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time Frame
This assessment will be collected upon enrollment in the study.
Title
Quadricep Isometric Strength: 1 Week
Description
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time Frame
This assessment will be collected 1-week into treatment.
Title
Quadricep Isometric Strength: 4 Weeks
Description
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time Frame
This assessment will be collected 4-weeks into treatment.
Title
Quadricep Isometric Strength: 9 Weeks/Discharge
Description
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time Frame
This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of patellofemoral pain syndrome (PFPS) or non-specific anterior knee pain (NSAKP) and plan to attend Gaylord Specialty Healthcare Physical Therapy Exclusion Criteria: Member of a defined vulnerable population, women who are or suspected to be pregnant, prisoners, children under 15, or other protected populations Body mass of the leg preventing the cuff from fitting properly Radiographic evidence of osteoarthritis (β‰₯ Kellgren-Lawrence Grade 2) History of intra-articular injection into either knee within 3 -months Uncontrolled or untreated inflammatory disorder Acute inflammatory disorder Uncontrolled Diabetes and/or peripheral neuropathy, impaired circulation Uncontrolled cardiac conditions including uncontrolled hypertension Areas of thrombophlebitis, thrombosis Distal wounds or pain below the knee >4/10 History of or current rhabdomyolysis Prolonged immobilization (>3 months) Sickle cell anemia Lymphadenectomy Varicose veins, or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis Current infection at or below the level of cuff placement Malignancies in or below the area to be treated Other conditions/medications that would interfere with subject safety or data collection in the opinion of the PI Subjects with an increased risk of non-response as determined by the therapist Once entered in the study, a diagnosis change that affects participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric Sokolowski
Organizational Affiliation
Physical Therapist
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Danielle Letendre
Organizational Affiliation
Physical Therapist
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gaylord Specialty Healthcare Outpatient Physical Therapy; Cheshire
City
Cheshire
State/Province
Connecticut
ZIP/Postal Code
06410
Country
United States
Facility Name
Gaylord Specialty Healthcare Outpatient Physical Therapy; Cromwell
City
Cromwell
State/Province
Connecticut
ZIP/Postal Code
06416
Country
United States
Facility Name
University of Connecticut Health Center
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030
Country
United States
Facility Name
Gaylord Specialty Healthcare Outpatient Physical Therapy; Madison
City
Madison
State/Province
Connecticut
ZIP/Postal Code
06443
Country
United States
Facility Name
Gaylord Hospital
City
Wallingford
State/Province
Connecticut
ZIP/Postal Code
06492
Country
United States
Facility Name
Gaylord Specialty Healthcare Outpatient Physical Therapy; Wallingford
City
Wallingford
State/Province
Connecticut
ZIP/Postal Code
06492
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Deidentified data will become available to researchers that are interesting after analysis has been completed. Data will be available for 3 years after the date of completion.
IPD Sharing Time Frame
Data will become available after analysis has been completed, and then will be available for 3 years after the date of completion.
IPD Sharing Access Criteria
Qualified researchers will be allowed access to the deidentified data, and any other documents at the discretion of the primary investigators and research team
Citations:
PubMed Identifier
29324820
Citation
Smith BE, Selfe J, Thacker D, Hendrick P, Bateman M, Moffatt F, Rathleff MS, Smith TO, Logan P. Incidence and prevalence of patellofemoral pain: A systematic review and meta-analysis. PLoS One. 2018 Jan 11;13(1):e0190892. doi: 10.1371/journal.pone.0190892. eCollection 2018.
Results Reference
background
PubMed Identifier
23242955
Citation
Collins NJ, Bierma-Zeinstra SM, Crossley KM, van Linschoten RL, Vicenzino B, van Middelkoop M. Prognostic factors for patellofemoral pain: a multicentre observational analysis. Br J Sports Med. 2013 Mar;47(4):227-33. doi: 10.1136/bjsports-2012-091696. Epub 2012 Dec 13.
Results Reference
background
PubMed Identifier
26463119
Citation
Lankhorst NE, van Middelkoop M, Crossley KM, Bierma-Zeinstra SM, Oei EH, Vicenzino B, Collins NJ. Factors that predict a poor outcome 5-8 years after the diagnosis of patellofemoral pain: a multicentre observational analysis. Br J Sports Med. 2016 Jul;50(14):881-6. doi: 10.1136/bjsports-2015-094664. Epub 2015 Oct 13.
Results Reference
background
PubMed Identifier
29794307
Citation
Maclachlan LR, Matthews M, Hodges PW, Collins NJ, Vicenzino B. The psychological features of patellofemoral pain: a cross-sectional study. Scand J Pain. 2018 Apr 25;18(2):261-271. doi: 10.1515/sjpain-2018-0025.
Results Reference
background
PubMed Identifier
28437494
Citation
Post WR, Dye SF. Patellofemoral Pain: An Enigma Explained by Homeostasis and Common Sense. Am J Orthop (Belle Mead NJ). 2017 Mar/Apr;46(2):92-100.
Results Reference
background
PubMed Identifier
29392329
Citation
Saltychev M, Dutton RA, Laimi K, Beaupre GS, Virolainen P, Fredericson M. Effectiveness of conservative treatment for patellofemoral pain syndrome: A systematic review and meta-analysis. J Rehabil Med. 2018 May 8;50(5):393-401. doi: 10.2340/16501977-2295.
Results Reference
background
PubMed Identifier
24673446
Citation
Powers CM, Ho KY, Chen YJ, Souza RB, Farrokhi S. Patellofemoral joint stress during weight-bearing and non-weight-bearing quadriceps exercises. J Orthop Sports Phys Ther. 2014 May;44(5):320-7. doi: 10.2519/jospt.2014.4936. Epub 2014 Mar 27.
Results Reference
background
PubMed Identifier
29925502
Citation
Collins NJ, Barton CJ, van Middelkoop M, Callaghan MJ, Rathleff MS, Vicenzino BT, Davis IS, Powers CM, Macri EM, Hart HF, de Oliveira Silva D, Crossley KM. 2018 Consensus statement on exercise therapy and physical interventions (orthoses, taping and manual therapy) to treat patellofemoral pain: recommendations from the 5th International Patellofemoral Pain Research Retreat, Gold Coast, Australia, 2017. Br J Sports Med. 2018 Sep;52(18):1170-1178. doi: 10.1136/bjsports-2018-099397. Epub 2018 Jun 20.
Results Reference
background
PubMed Identifier
17512484
Citation
Kountouris A, Cook J. Rehabilitation of Achilles and patellar tendinopathies. Best Pract Res Clin Rheumatol. 2007 Apr;21(2):295-316. doi: 10.1016/j.berh.2006.12.003.
Results Reference
background
PubMed Identifier
33940556
Citation
Song JS, Spitz RW, Yamada Y, Bell ZW, Wong V, Abe T, Loenneke JP. Exercise-induced hypoalgesia and pain reduction following blood flow restriction: A brief review. Phys Ther Sport. 2021 Jul;50:89-96. doi: 10.1016/j.ptsp.2021.04.005. Epub 2021 Apr 23.
Results Reference
background
PubMed Identifier
24505397
Citation
Misra G, Paris TA, Archer DB, Coombes SA. Dose-response effect of isometric force production on the perception of pain. PLoS One. 2014 Feb 4;9(2):e88105. doi: 10.1371/journal.pone.0088105. eCollection 2014.
Results Reference
background
PubMed Identifier
32105522
Citation
Hughes L, Patterson SD. The effect of blood flow restriction exercise on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid mechanisms of pain modulation. J Appl Physiol (1985). 2020 Apr 1;128(4):914-924. doi: 10.1152/japplphysiol.00768.2019. Epub 2020 Feb 27.
Results Reference
background
PubMed Identifier
28500081
Citation
Giles L, Webster KE, McClelland J, Cook JL. Quadriceps strengthening with and without blood flow restriction in the treatment of patellofemoral pain: a double-blind randomised trial. Br J Sports Med. 2017 Dec;51(23):1688-1694. doi: 10.1136/bjsports-2016-096329. Epub 2017 May 12.
Results Reference
background
PubMed Identifier
34985237
Citation
Constantinou A, Mamais I, Papathanasiou G, Lamnisos D, Stasinopoulos D. Comparing hip and knee focused exercises versus hip and knee focused exercises with the use of blood flow restriction training in adults with patellofemoral pain. Eur J Phys Rehabil Med. 2022 Apr;58(2):225-235. doi: 10.23736/S1973-9087.22.06691-6. Epub 2022 Jan 5.
Results Reference
background
PubMed Identifier
21654093
Citation
Dolak KL, Silkman C, Medina McKeon J, Hosey RG, Lattermann C, Uhl TL. Hip strengthening prior to functional exercises reduces pain sooner than quadriceps strengthening in females with patellofemoral pain syndrome: a randomized clinical trial. J Orthop Sports Phys Ther. 2011 Aug;41(8):560-70. doi: 10.2519/jospt.2011.3499. Epub 2011 Jun 7. Erratum In: J Orthop Sports Phys Ther. 2011 Sep;41(9):700.
Results Reference
background
PubMed Identifier
31773479
Citation
Sisk D, Fredericson M. Update of Risk Factors, Diagnosis, and Management of Patellofemoral Pain. Curr Rev Musculoskelet Med. 2019 Dec;12(4):534-541. doi: 10.1007/s12178-019-09593-z.
Results Reference
background
PubMed Identifier
35090543
Citation
Brightwell BD, Stone A, Li X, Hardy P, Thompson K, Noehren B, Jacobs C. Blood flow Restriction training After patellar INStability (BRAINS Trial). Trials. 2022 Jan 28;23(1):88. doi: 10.1186/s13063-022-06017-1.
Results Reference
background
PubMed Identifier
24265891
Citation
Thiebaud RS, Yasuda T, Loenneke JP, Abe T. Effects of low-intensity concentric and eccentric exercise combined with blood flow restriction on indices of exercise-induced muscle damage. Interv Med Appl Sci. 2013 Jun;5(2):53-9. doi: 10.1556/IMAS.5.2013.2.1. Epub 2013 Jul 4.
Results Reference
background

Learn more about this trial

Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy

We'll reach out to this number within 24 hrs